Get started
Author

Pedro Simoes

Mpox in people with advanced HIV infection: a global case series
2023 · Oriol Mitjà, Andrea Alemany, et al. · The Lancet · 508
PDF
Clinical features and management of individuals admitted to hospital with monkeypox and associated complications across the UK: a retrospective cohort study
2022 · Douglas L Fink, Douglas L Fink, et al. · The Lancet Infectious Diseases · 99
PDF
Real world use of dolutegravir two drug regimens
2023 · Conor Bowman, Alissa Ambrose, et al. · AIDS · 17
HIV/HBV coinfection remodels the immune landscape and natural killer cell ADCC functional responses
2024 · Bo Sun, Kelly A.S. da Costa, et al. · Hepatology · 10
PDF
Stem-like CD8+ T cells preserve HBV-specific responses in HBV/HIV co-infection
2025 · Anucha Preechanukul, Aljawharah Alrubayyi, et al. · Gut · 5
Switch to once-weekly, single-tablet islatravir–lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial
2026 · Amy E Colson, Princy N Kumar, et al. · The Lancet · 3
61 Development of antiretroviral drug resistance in the context of gastroparesis: A learning opportunity
2025 · Malin Bergstrom, Alfredo Pinheiro Martins, et al. · Clinical Infection in Practice · 1
Preserved CD4 + T cell helper function and coordinated antiviral immunity in people with HBV/HIV co-infection on long-term therapy
2026 · Aljawharah Alrubayyi, Anucha Preechanukul, et al. · bioRxiv (Cold Spring Harbor Laboratory)
Patient Characteristics and Reasons for Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Retrospective Cohort From a Large Urban HIV Clinic
2025 · Hao Gao, Bhavya Manchukonda, et al. · Cureus
PDF
Stem-like CD8+ T cells preserve HBV-specific responses in HBV/HIV co-infection
2025 · Jay Preechanukul, Aljawharah Alrubayyi, et al. · medRxiv
Works count: 10
Citation count: 643
H-index: 5
I10-index: 4
Year
Topic
Type